Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Perseus Proteomics continues to rise on subsidy for aggressive NK-cell leukemia treatment drug development
FY2026 Medical R&D Program grant awarded for development of PPMX-T003 Aggressive NK-Cell leukemia
Notice Regarding Full-Year Earnings Forecast for the FY2026/3
Perseus Proteomics, The Current Fiscal Year's Undisclosed Net Income to Narrow
Perseus Proteomics Inc. Announces Notice of Allowance in the U.S. for Patent Relating to Antibody-Based Radiopharmaceutical Formulation Technology
Announcement of a Presentation at an International Symposium Regarding PPMX-T003
Non-consolidated Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026
Notice on Recording of Non-operating Income, Non-operating Expenses, and Extraordinary Losses
Perseus Proteomics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Announcement of Presentation at The 4th Annual Meeting of The Japanese Antibody Society
Notice of Joint Research Agreement with Eurus Therapeutics Inc. for the Utilization of PPMX Antibody Library
Presentation Material for FY2026/3 First Half Business Results
Notice on Recording of Non-operating Income, Non-operating Expenses, and Extraordinary Losses
Perseus Proteomics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Narrows
Non-consolidated Summary of Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2026
Notice of Extension of Investigator-Initiated Phase I/II Clinical Trial Period for PPMX-T003 in Aggressive NK-Cell Leukemia (ANKL)
Notice Regarding Execution of Joint Research Agreement between PPMX and ASKA Pharmaceutical for Creation of Novel Antibody Drugs
Announcement of New Antibody and Reagent Product Launch
Announcement of Acceptance for Three Poster Presentations at the 4th Annual Meeting of the Japan Antibody Society
Notice of Selection for JST A-STEP Program-Industry-Academia Collaboration Stage II (Full-Scale Phase)